Iwaki & Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Iwaki & Co., Ltd. with three other
companies in this sector in Japan:
Torii Pharmaceutical Co., Ltd.
sales of 60.21 billion Japanese Yen [US$535.23 million]
of which 100%
Zeria Pharmaceutical Co Ltd
(62.48 billion Japanese Yen [US$555.40 million]
of which 54%
was Pharmaceuticals Business), and
CMIC Holdings Co Ltd
(62.04 billion Japanese Yen [US$551.53 million]
of which 47%
was Cro Business).
Iwaki & Co., Ltd. reported sales of ¥55.12 billion (US$490.03 million)
November of 2016.
decrease of 0.5%
versus 2015, when the company's sales were ¥55.42 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Iwaki & Co., Ltd. had sales
of ¥53.80 billion.